Home › NDC Lookup › Ingredients › Docusate Sodium › 67618-0111-28
Colace Docusate sodium 50 mg Capsule, Liquid Filled, 28-count — NDC 67618-0111-28 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Colace Docusate sodium 50 mg Capsule, Liquid Filled, 28-count — NDC 67618-111-28 (Billing 67618-0111-28)

by Atlantis Consumer Healthcare, Inc. · 1 BOTTLE in 1 CARTON / 28 CAPSULE, LIQUID FILLED in 1 BOTTLE

This is a package of 28 capsules of Colace Docusate sodium 50 mg Capsule, Liquid Filled from Atlantis Consumer Healthcare, Inc., marketed since Jan 1900 and currently FDA-listed; retail pharmacies pay about $0.2563 per capsule (NADAC). It is the main listing for this product, which comes in 4 package sizes.

NDC 67618-0111-28
🏷️ FDA NDC (as labeled) 67618-111-28 billing pads the product segment with a zero
This package
Contains28-count Cost per ea$0.2563 NADAC Per package$7.18 / 28 capsules Pack sizes4 compare ↓
Also priced by: Medicaid pays $0.3528/unit — full pricing hub ↓
Main listing for product 67618-111 · Also comes in: 42 capsules 67618-111-42 60 capsules 67618-111-60 100 capsules 67618-111-10
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Sep 10, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 67618-111-28
Product NDC 67618-111
11-digit billing NDC 67618011128
NCPDP billing unit EA — each (per item)
RxCUI 1247759, 1247761
UNII F05Q2T2JA0
UPC 0367618000076, 0367618111284, 0367618000007
Application # M007
SPL Set ID a1591da0-a1a9-9583-3cf5-788b8fee3814
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 1900-01-07
Route ORAL
Dosage form CAPSULE, LIQUID FILLED
Substance DOCUSATE SODIUM

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 003013
GCN 09105
HICL code 001326
Ingredient (HICL) Docusate Sodium
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Colon
HIC3 code D6S
Therapeutic class — specific (HIC3) Laxatives And Cathartics
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name COLACE CLEAR 50 MG SOFTGEL
FDB brand name Colace Clear
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 003013
  • GCN: 09105
  • HICL (First Databank): 001326
  • AHFS class code: 56:12.00.00
  • RxCUI (RxNorm): 1247759
Why two NDCs? The FDA registers this code as 67618-111-28 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 67618-0111-28. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Softeners, emollients class.

Drug family (ATC) Softeners, emollients
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name COLACE CLEAR 50 MG SOFTGEL Ingredient Docusate Sodium
🧪 What is this product?

Colace is an over-the-counter oral capsule containing docusate sodium, a stool softener. This product is an OTC monograph drug, meaning it is marketed under FDA's established rules for this category of medicine. Docusate sodium is typically used to soften stool and ease bowel movements, commonly taken by people who want to avoid straining during defecation.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.256 $7.18 / 28 capsules
Medicaid paysCMS SDUD · 12 mo $0.3528 $9.88 / 28 capsules
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Feb 2024 Dec 2025 Jan 2026 May 2026 $0.256 $0.254
Flat over the last 5 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
67618-0111-28 You're viewing this Main listing 1 BOTTLE in 1 CARTON / 28 CAPSULE, LIQUID FILLED in 1 BOTTLE $0.2563 / ea $7.18 1900-01-07 — Active
67618-0111-10 67618-111-10 1 BOTTLE in 1 CARTON / 100 CAPSULE, LIQUID FILLED in 1 BOTTLE — — 2025-12-01 — Active
67618-0111-42 67618-111-42 1 BOTTLE in 1 CARTON / 42 CAPSULE, LIQUID FILLED in 1 BOTTLE — — 2024-02-01 — Active
67618-0111-60 67618-111-60 1 BOTTLE in 1 CARTON / 60 CAPSULE, LIQUID FILLED in 1 BOTTLE — — 2024-04-01 — Active

In Medicaid, this is the most-dispensed pack of this product — about 100% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This is a 28-count package — 1 bottle in 1 carton / 28 capsule, liquid filled in 1 bottle.
How does this package differ from NDC 67618-0111-42?
Both are Colace Docusate sodium 50 mg Capsule, Liquid Filled — the drug itself is identical. This page's package is the 28-count one, while NDC 67618-0111-42 is the 42 capsules package.
What NDC number is used to bill for this package of Colace Docusate sodium 50 mg Capsule, Liquid Filled?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Colace 50 mgthis 67618-0111-28 Atlantis 28 capsules $0.256 — Availability likely —
Docusate Sodium 50Mg Softgel (Red) 50 mg 51316-0651-01 CVS 100 capsules — — FDA listed —
Docusate Sodium softgels 50mg (Dye Free) 50 mg 51316-0652-03 CVS 30 capsules — — FDA listed —
Docusate Sodium 50 Mg 53345-0015-01 Humanwell 20000 capsules — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
1900
On the market since
Jan 1900
📍
2026
Currently FDA-listed
126 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color Brown
ShapeOval
ImprintCLR;50
Size11 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 2G86QN327L
    Gelatin is a protein derived from animal collagen, commonly used in medicines as a gelling agent and capsule material. It helps create soft or hard capsule shells that hold and release medication, and can also thicken liquid formulations.
  • UNII PDC6A3C0OX
    Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
  • UNII B697894SGQ
    Polyethylene glycol 400 is a clear, thick liquid made from petroleum-derived polymers. It acts as a solvent and humectant in medicines, helping dissolve active ingredients and retain moisture in the formulation.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII 506T60A25R
    Sorbitol is a natural sugar alcohol derived from glucose. It serves as a sweetener, humectant, and bulking agent in medications to improve taste and help maintain moisture in the product.

5 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesInactive ingredients gelatin, glycerin, PEG 400, propylene glycol, sorbitol Soft gels are imprinted with edible dye-free ink. Dist. by: Atlantis Consumer Healthcare Inc. Bridgewater, NJ 08807 Questions? 1-833-288-2684 ©2023 Atlantis Consumer Healthcare Inc. Colace is a registered trademark of Atlantis Consumer Healthcare Inc.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAtlantis Consumer Healthcare, Inc.
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code67618
First marketedJan 1900
Product typeHuman Otc Drug
Portfolio17 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 💊 Dosage Forms and Strengths 📦 How Supplied / Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 14 words ▾

Uses relieves occasional constipation (irregularity) generally produces bowel movement in 12 to 72 hours

💊 Dosage Forms and Strengths 50 words ▾

Directions Take only by mouth. Doses may be taken as a single daily dose or in divided doses. adults and children 12 years and over take 1-6 soft gels daily children 2 to under 12 years of age take 1-3 soft gels daily children under 2 years ask a doctor

📦 How Supplied / Storage and Handling 24 words ▾

Other information each soft gel contains: sodium 3 mg VERY LOW SODIUM store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F). Keep tightly closed.

🧪 Active Ingredient 2 words ▾

Drug Facts

🧪 Inactive Ingredients 43 words ▾

Inactive ingredients gelatin, glycerin, PEG 400, propylene glycol, sorbitol Soft gels are imprinted with edible dye-free ink. Dist. by: Atlantis Consumer Healthcare Inc. Bridgewater, NJ 08807 Questions? 1-833-288-2684 ©2023 Atlantis Consumer Healthcare Inc. Colace is a registered trademark of Atlantis Consumer Healthcare Inc.

🎯 Purpose 13 words ▾

Active ingredient Purpose (in each soft gel) Docusate sodium 50 mg........... Stool softener

📄 Do Not Use 19 words ▾

Warnings Do not use if you are presently taking mineral oil, unless told to do so by a doctor

📄 Ask a Doctor Before Use If 24 words ▾

Ask a doctor before use if you have stomach pain nausea vomiting noticed a sudden change in bowel habits that lasts over 2 weeks

📄 Stop Use and Ask a Doctor If 42 words ▾

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movementafter use of a laxative. These could be signs of a serious condition. you need to use a stool softener laxative for more than1 week

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel ~3 min read ▾

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Colace ® Docusate Sodium, 50mg CLEAR Stool Softener 28 Clear soft gels Do not use an imprinted seal under cap is missing or damaged. See carton for additional information. Dist. by: Atlantis Consumer Healthcare Inc.

A0925 Bridgewater, NJ 08807 USA Questions? 1-833-288-2684 R54005 Lot No.: Exp. Date: Front Panel #1 DOCTOR RECOMMENDED Stool Softener Brand Colace ® Docusate Sodium, 50mg CLEAR Stool Softener √ Gentle, Effective Constipation Relief √ Stimulant-Free & Dye-Free 28 Clear Soft Gels Side Panel Colace ® Docusate Sodium, 50mg Retain this carton for Important information.

For added savings, visit: colacecapsules.com Dist. by: Atlantis Consumer Healthcare Inc. Bridgewater, NJ 08807 USA Questions? 1-833-288-2684 A0925 ©2025 Atlantis Consumer Healthcare Inc.

Colace is a registered trademark of Atlantis Consumer Healthcare Inc. R54009 Lot No.: Exp. Date: Colace ® Docusate Sodium, 50mg CLEAR Stool Softener 42 Clear soft gels Do not use an imprinted seal under cap is missing or damaged.

See carton for additional information. Dist. by: Atlantis Consumer Healthcare Inc. A0925 Bridgewater, NJ 08807 USA Questions?

1-833-288-2684 R54008 Lot No.: Exp. Date: Front Panel #1 DOCTOR RECOMMENDED Stool Softener Brand Colace ® Docusate Sodium, 50mg CLEAR Stool Softener √ Gentle, Effective Constipation Relief √ Stimulant-Free & Dye-Free 42 Clear Soft Gels Side Panel Colace ® Docusate Sodium, 50mg √ Dye & Preservative-Free √ Stimulant -Free √ No Artificial Sweeteners Retain this carton for Important information. For added savings, visit: colacecapsules.com R54009 Dist. by: Atlantis Consumer Healthcare Inc.

Bridgewater, NJ 08807 USA Questions? 1-833-288-2684 ©2025 Atlantis Consumer Healthcare Inc. Colace is a registered trademark of Atlantis Consumer Healthcare Inc.

Lot No.: Exp. Date: A0925 Colace ® Docusate Sodium, 50mg CLEAR Stool Softener 60 Clear Soft Gels Do not use an imprinted seal under cap is missing or damaged. See carton for additional information.

Dist. by: Atlantis Consumer Healthcare Inc. A0925 Bridgewater, NJ 08807 USA Questions? 1-833-288-2684 R54010 Lot No.: Exp.

Date: Front Panel #1 DOCTOR RECOMMENDED Stool Softener Brand Colace ® Docusate Sodium, 50mg CLEAR Stool Softener √ Gentle, Effective Constipation Relief √ Stimulant-Free & Dye-Free 60 Clear Soft Gels Side Panel Colace ® Docusate Sodium, 50mg √ Dye & Preservative-Free √ Stimulant -Free √ No Artificial Sweeteners Retain this carton for Important information. For added savings, visit: colacecapsules.com R54011 Dist. by: Atlantis Consumer Healthcare Inc. Bridgewater, NJ 08807 USA Questions?

1-833-288-2684 ©2025 Atlantis Consumer Healthcare Inc. Colace is a registered trademark of Atlantis Consumer Healthcare Inc. Lot No.: Exp.

Date: A0925 Colace ® Docusate Sodium, 50mg CLEAR Stool Softener 100 Clear Soft Gels Do not use an imprinted seal under cap is missing or damaged. See carton for additional information. Dist. by: Atlantis Consumer Healthcare Inc.

Bridgewater, NJ 08807 USA Questions? 1-833-288-2684 R54367 Lot No.: Exp. Date: A0925 Front Panel VALUE SIZE #1 DOCTOR RECOMMENDED Stool Softener Brand Colace ® Docusate Sodium, 50mg CLEAR Stool Softener √ Gentle, Effective Constipation Relief √ Stimulant-Free & Dye-Free 100 Clear Soft Gels Side Panel Colace ® Docusate Sodium, 50mg √ Dye & Preservative-Free √ Stimulant -Free √ No Artificial Sweeteners Retain this carton for Important information.

For added savings, visit: colacecapsules.com Dist. by: Atlantis Consumer Healthcare Inc. Bridgewater, NJ 08807 USA Questions? 1-833-288-2684 ©2025 Atlantis Consumer Healthcare Inc.

Colace is a registered trademark of Atlantis Consumer Healthcare Inc. Actual size bottle R54366 Lot No.: Exp. Date: A0925

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
5.5K
Units reimbursed last 4 qtrs
247.2K
Gross reimbursed last 4 qtrs
$87.2K
Avg / prescription
$16.00
Avg / unit
$0.3528
Latest quarter Q1 2026
1.3KRx
Medicaid pays / ea
$0.3528
gross reimbursed
vs
NADAC / ea
$0.2563
acquisition cost
=
Spread
+$0.0965
+38% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
32% FFS 68% MCO
Fee-for-service · 1,762 Rx Managed care · 3,689 Rx
State Medicaid map
Alaska: no data reported AK Maine: 2,188 units · 157 per 100k residents ME Washington: no data reported WA Idaho: no data reported ID Montana: 2,423 units · 214 per 100k residents MT North Dakota: no data reported ND Minnesota: 10,733 units · 187 per 100k residents MN Wisconsin: 5,549 units · 93.9 per 100k residents WI Michigan: 41,556 units · 414 per 100k residents MI New York: no data reported NY Vermont: no data reported VT New Hampshire: 1,856 units · 132 per 100k residents NH Oregon: 4,720 units · 112 per 100k residents OR Nevada: 4,846 units · 152 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 6,024 units · 48.0 per 100k residents IL Indiana: no data reported IN Ohio: no data reported OH Pennsylvania: 63,638 units · 491 per 100k residents PA New Jersey: 4,190 units · 45.1 per 100k residents NJ Massachusetts: no data reported MA California: 23,773 units · 61.0 per 100k residents CA Utah: no data reported UT Colorado: 9,785 units · 166 per 100k residents CO Nebraska: 7,639 units · 386 per 100k residents NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: 5,626 units · 64.5 per 100k residents VA Maryland: 2,081 units · 33.7 per 100k residents MD Connecticut: no data reported CT Rhode Island: 4,604 units · 420 per 100k residents RI Arizona: 15,224 units · 205 per 100k residents AZ New Mexico: no data reported NM Kansas: 3,694 units · 126 per 100k residents KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: 18,904 units · 352 per 100k residents SC Delaware: 3,482 units · 338 per 100k residents DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: 727 units · 24.7 per 100k residents MS Alabama: no data reported AL Georgia: 586 units · 5.3 per 100k residents GA D.C.: 3,351 units · 494 per 100k residents DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
5.3494
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 D.C. 494 /100k
2 Pennsylvania 491 /100k
3 Rhode Island 420 /100k
4 Michigan 414 /100k
5 Nebraska 386 /100k
6 South Carolina 352 /100k
7 Delaware 338 /100k
8 Montana 214 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
28 capsules this page67618-0111-28 5,451 Rx · $87,205
100 capsules67618-0111-10 No Medicaid data
42 capsules67618-0111-42 No Medicaid data
60 capsules67618-0111-60 No Medicaid data
Drug total (last 4 qtrs): 5,451 Rx · 247,199 units · $87,205 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.
← 67618-0110-10 · Atlantis 67618-0120-06 · Atlantis →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.